title: Philadelphia chromosome-negative myeloproliferative neoplasm with a novel platelet-derived growth factor receptor-β rearrangement responsive to imatinib.
authors.affiliation: Lehigh Valley Hospital, Allentown, PA, USA.
authors.forename: Dennis
authors.initials: D
authors.lastname: Cornfield
authors.forename: Usman
authors.initials: U
authors.lastname: Shah
authors.forename: Nicholas
authors.initials: N
authors.lastname: Cross
authors.forename: Courtney
authors.initials: C
authors.lastname: Bennett
authors.forename: Guoxian
authors.initials: G
authors.lastname: Sun
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D015321:Gene Rearrangement; D006801:Humans; D000068877:Imatinib Mesylate; D017404:In Situ Hybridization, Fluorescence; D008297:Male; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000188:drug therapy* / Q000235:genetics*; D010677:Philadelphia Chromosome; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D020797:Receptor, Platelet-Derived Growth Factor beta / Q000235:genetics*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D020797:Receptor, Platelet-Derived Growth Factor beta